Fed Circuit rejects Stanford Uni’s ‘abstract’ genetics patent
15-03-2021
Choreograph / iStockphoto.com
Stanford University has entered into a licensing agreement with Madenco Biosciences to develop and commercialise patented epidermal growth factor (EGF) wound healing technology.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Stanford University; Madenco Biosciences; Quest PharmaTech; Jennifer Chochran; Massachusetts Institute of Technology; cosmetics; healthcare; Madi Madiyalak
